PD-0325 Feasibility and safety of MR-guided stereotactic ablative body radiotherapy for Prostate Cancer. (May 2022) - Geddes, L.; Crawford, D.; Batumalai, V.; Pagulayan, C.; Hogan, L.; Jelen, U.; Loo, C.; Dunkerley, N.; Picton, M.; Alvares, S.; Sampaio, S.; Heinke, M.; et al.